Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination

None

Saved in:
Bibliographic Details
Main Authors: Parisi, Sarah, Curti, Antonio
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2012
Subjects:
Online Access:https://www.intechopen.com/chapters/31173
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839566913522368512
author Parisi, Sarah
Curti, Antonio
author_facet Parisi, Sarah
Curti, Antonio
author_sort Parisi, Sarah
collection InTech Open eBooks
description None
doi_str_mv 10.5772/34302
first_indexed 2025-08-04T22:48:38Z
format Electronic
Book Chapter
fullrecord <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>InTech-31173</identifier><datestamp>2012-03-02</datestamp> <dc:title>Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination</dc:title> <dc:creator>Sarah Parisi</dc:creator> <dc:creator>Antonio Curti</dc:creator> <dc:subject>Health Sciences</dc:subject> <dc:description>None</dc:description> <dc:publisher>IntechOpen</dc:publisher> <dc:date>2012-03-02</dc:date> <dc:type>Chapter, Part Of Book</dc:type> <dc:identifier>https://www.intechopen.com/chapters/31173</dc:identifier> <dc:identifier>doi:10.5772/34302</dc:identifier> <dc:language>en</dc:language> <dc:relation>ISBN:978-953-51-0174-1</dc:relation> <dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights> <dc:source>https://www.intechopen.com/books/1830 ; Hematology - Science and Practice</dc:source> </oai_dc:dc>
id InTech-31173
institution Matheson Library
isbn 978-953-51-0174-1
language English
last_indexed 2025-08-04T22:48:38Z
publishDate 2012
publisher IntechOpen
record_format intech
spelling InTech-311732012-03-02 Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination Sarah Parisi Antonio Curti Health Sciences None IntechOpen 2012-03-02 Chapter, Part Of Book https://www.intechopen.com/chapters/31173 doi:10.5772/34302 en ISBN:978-953-51-0174-1 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/1830 ; Hematology - Science and Practice
spellingShingle Health Sciences
Parisi, Sarah
Curti, Antonio
Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title_full Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title_fullStr Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title_full_unstemmed Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title_short Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
title_sort targeting the minimal residual disease in acute myeloid leukemia the role of adoptive immunotherapy with natural killer cells and antigen specific vaccination
topic Health Sciences
url https://www.intechopen.com/chapters/31173
work_keys_str_mv AT parisisarah targetingtheminimalresidualdiseaseinacutemyeloidleukemiatheroleofadoptiveimmunotherapywithnaturalkillercellsandantigenspecificvaccination
AT curtiantonio targetingtheminimalresidualdiseaseinacutemyeloidleukemiatheroleofadoptiveimmunotherapywithnaturalkillercellsandantigenspecificvaccination